文献速递心境障碍焦虑、强迫与应激相关障碍物质与行为成瘾

全球育龄女性精神与物质使用障碍疾病负担分析

Global burden of diseases attributed to mental and substance use disorders in reproductive-age women: an ecological analysis for the Global Burden of Disease Study 2021.
PubMed 文献 · Mol Psychiatry · 2025-09-08

基于全球疾病负担研究2021数据,分析1990至2021年育龄女性12种精神与物质使用障碍的患病率、发病率和伤残损失寿命年。2021年精神障碍年龄标化患病率为每10万人17573,物质使用障碍为1806;抑郁和焦虑障碍是YLD主要贡献者。1990至2021年精神障碍负担上升,物质使用障碍负担下降,高社会人口指数地区负担最高。

要点

  • 2021年育龄女性精神障碍年龄标化患病率为每10万人17573,物质使用障碍为1806。
  • 抑郁和焦虑障碍是YLD主要贡献者,年龄标化YLD率分别为每10万人1073.5和844.05。
  • 1990至2021年精神障碍负担上升,物质使用障碍负担下降,15-24岁女性精神障碍负担增加最明显。

核心结论

  • 精神与物质使用障碍是育龄女性全球疾病负担的重要贡献因素,其规模与分布随障碍类型、国家、年龄组和社会人口发展水平而异。

研究设计与样本

  • 基于全球疾病负担研究2021数据的生态学分析,评估1990至2021年育龄女性12种精神与物质使用障碍的患病率、发病率和YLD,按年龄、性别及全球、区域、国家层面分层。

主要发现

  • 2021年育龄女性精神障碍年龄标化患病率为每10万人17573(95%UI 15443-19954),物质使用障碍为1806(95%UI 484-2191)。
  • 抑郁和焦虑障碍是YLD主要贡献者,年龄标化YLD率分别为每10万人1073.5(95%UI 686.73-1562.48)和844.05(95%UI 532.79-1232.57)。
  • 1990至2021年精神障碍的患病率、发病率和YLD年龄标化率均上升(AAPC分别为35%、55%、38%),物质使用障碍均下降(AAPC分别为-55%、-62%、-19%)。
  • 精神与物质使用障碍负担均在社会人口指数较高地区最高,精神障碍负担在15-24岁女性中增加最大,物质使用障碍在15-34岁女性中增加最大。

临床怎么用

  • 关注育龄女性精神障碍负担上升趋势,尤其抑郁和焦虑障碍的YLD贡献。
  • 针对高社会人口指数地区和年轻女性(15-24岁精神障碍、15-34岁物质使用障碍)加强筛查与干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A comprehensive analysis of the global burden and trends of mental disorders (MDs) and substance use disorders (SUDs) among reproductive-age women is lacking. This study estimated the burden of disease attributable to MDs and SUDs in reproductive-age women from 1990 to 2021. Using data from the Global Burden of Disease Study 2021, we assessed the prevalence, incidence, and years lived with disability (YLDs) of 12 types of MDs and SUDs among reproductive-age women between 1990 and 2021. Estimates were stratified by age and sex at global, regional, and national levels. Trends were evaluated using the average annual percentage change (AAPC) and total percentage change. In 2021, the global age-standardized prevalence rates per 100,000 population among reproductive-age women were 17,573 (95% uncertainty interval 15,443-19,954) for MDs and 1806 (95% uncertainty interval 484-2191) for SUDs. Among MDs, depressive and anxiety disorders were the leading contributors to YLDs, with age-standardized YLD rates of 1,073.5 (686.73-1,562.48) and 844.05 (532.79-1,232.57) per 100,000 population, respectively. From 1990 to 2021, age-standardized rates of the prevalence, incidence, and YLDs of MDs increased (AAPC: 35%, 55%, and 38%, respectively), while those of SUDs decreased (AAPC: -55%, -62%, and -19%, respectively). The burden of both MDs and SUDs was highest in regions with higher sociodemographic indices. The greatest increases in burden were observed among younger women aged 15-24 years with MDs and 15-34 years with SUDs. MDs and SUDs are substantial contributors to the global disease burden in reproductive-age women. The magnitude and distribution of this burden vary by disorder type, country, age group, and sociodemographic development.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Li C, Liang A, Kuang Y, et al. Global burden of diseases attributed to mental and substance use disorders in reproductive-age women: an ecological analysis for the Global Burden of Disease Study 2021. Mol Psychiatry. 2025. PMID: 40921795. doi:10.1038/s41380-025-03216-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。